Metabolic syndrome and risk for incident alzheimer's disease or vascular dementia

Diabetes Care

Volumn 32, Issue 1, 2009, Pages 169-174

  Raffaitin, Christelle ^a,b,c   Gin, Henri ^a   Empana, Jean Philippe ^b   Helmer, Catherine ^b,c   Berr, Claudine ^b,d,e   Tzourio, Christophe ^b   Portet, Florence ^b,d,e   Dartigues, Jean François ^b,c   Alpérovitch, Annick ^b   Barberger Gateau, Pascale ^b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d UNIV MONTPELLIER   (France)

^e MONTPELLIER UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ALZHEIMER DISEASE; ARTICLE; DEMOGRAPHY; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIINFARCT DEMENTIA; PROPORTIONAL HAZARDS MODEL; RISK; WAIST CIRCUMFERENCE;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CHOLESTEROL, HDL; COHORT STUDIES; DEMENTIA, VASCULAR; DIABETES COMPLICATIONS; FEMALE; FRANCE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; MALE; METABOLIC SYNDROME X; PROPORTIONAL HAZARDS MODELS; TRIGLYCERIDES; URBAN POPULATION;

EID: 64549131779     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0272     Document Type: Article

References (25)

1. Ritchie K, Lovestone S: The dementias. Lancet 360:1759-1766, 2002
2. Gorelick PB: Risk factors for vascular dementia and Alzheimer disease. Stroke 35 (11 Suppl. 1):2620-2622, 2004
3. Qiu C, Winblad B, Fratiglioni L: The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4:487-499, 2005
4. Gorospe EC, Dave JK: The risk of dementia with increased body mass index. Age Ageing 36:23-29, 2007
5. Reitz C, Tang MX, Luchsinger J, Mayeux R: Relation of plasma lipids to Alzheimer disease and vascular dementia. Arch Neu-rol 61:705-714, 2004
6. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P: Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5:64-74, 2006
7. Reaven GM: Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
8. Lakka HM, Laaksonen DE, Lakka TA, Nis-kanen LK, Kumpusalo E, Tuomilehto J, Sa-lonen JT: The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716, 2002
9. Kalmijn S, Foley D, White L, Burchfiel CM, Curb JD, Petrovitch H, Ross GW, Havlik RJ, Launer LJ: Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men: the Honolulu-Asia Aging Study. Arterioscler Thromb Vasc Biol 20:2255-2260, 2000
10. Yaffe K, Kanaya A, Lindquist K, Simon-sick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB: The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 292:2237-2242, 2004
11. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N: Metabolic syndrome and cognitive decline in elderly Latinos: findings from the Sacramento Area Latino Study of Aging study. J Am Geriatr Soc 55:758-762, 2007
12. Komulainen P, Lakka TA, Kivipelto M, Has-sinen M, Helkala EL, Haapala I, Nissinen A, Rauramaa R: Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Cogn Disord 23:29 -34, 2007
13. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K, Penninx BW: Contribution of metabolic syndrome components to cognition in older persons. Diabetes Care 30:2655-2660, 2007
14. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA: Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Dis-ord 24:185-192, 2007
15. Messier C: Impact of impaired glucose tolerance and type 2 diabetes on cognitive aging. Neurobiol Aging 26 (Suppl. 1):26- 30, 2005
16. The3CStudy Group: Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 22: 316-325, 2003
17. Grundy SM, Cleeman JI, Daniels SR, Do-nato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752, 2005
18. Gabir MM, Hanson RL, Dabelea D, Im-peratore G, Roumain J, Bennett PH, Knowler WC: Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 23:1113-1118, 2000
19. Lamarca R, Alonso J, Gomez G, Munoz A: Left-truncated data with age as time scale: an alternative for survival analysis in the elderly population. J Gerontol A Biol Sci Med Sci 53:M337-343, 1998
20. Ferrannini E: Is insulin resistance the cause of the metabolic syndrome? Ann Med 38:42-51, 2006
21. Perlmuter LC, Nathan DM, Goldfinger SH, Russo PA, Yates J, Larkin M: Triglyc-eride levels affect cognitive function in noninsulin-dependent diabetics. J Diabet Complications 2:210-213, 1988
22. Hokanson JE, Austin MA: Plasma tri-glyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219, 1996
23. Rosendorff C, Beeri MS, Silverman JM: Cardiovascular risk factors for Alzheimer's disease. Am J Geriatr Cardiol 16:143-149, 2007
24. Luchsinger JA, Patel B, Tang MX, Schupf N, Mayeux R: Measures of adiposity and dementia risk in elderly persons. Arch Neurol 64:392-398, 2007
25. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ 322: 1447-1451, 2001